BIOMAT Database Logo BIOMAT Database Logo

Action of Bauhinia bauhinioides synthetic peptides on serine proteinases. 2003

Cristina I Cagliari, and Fernanda P De Caroli, and Adriana M Nakahata, and Mariana S Araújo, and Clovis R Nakaie, and Misako U Sampaio, and Claudio A M Sampaio, and Maria Luiza V Oliva
Departamento de Bioquímica, Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo, Brazil.

The kallikrein inhibitor found in Bauhinia bauhinioides seeds (BbKI) differs from classical Kunitz plant inhibitors in the lack of disulfide bridges in its structure [Biochim. Biophys. Acta 1477 (2000) 64-74]. In this study, we examined whether structural properties may be involved in inhibitory specificity and, if so, whether those properties might be useful tools in designing compounds that interfere with enzyme activity. Peptides structurally related to the BbKI (RPGLPVRFESPLRINIIKE-NH(2)) reactive site were synthesized by solid-phase method and assayed for serine proteinase activity. The peptides RPGLPVRFESPLRINIIKE-NH(2), RPGLPVRFESPL-NH(2), and GLPVRFES-NH(2) were efficient tissue kallikrein inhibitors, with I(50) values of 0.54 microM, 0.87 microM, and 0.5mM, respectively. The lasting inhibitory effect was observed in incubation periods of up to 120 min. None of the studied peptides interfere with the activity of thrombin, factor Xa or trypsin, although the native protein BbKI is a potent trypsin inhibitor.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D010940 Plant Proteins Proteins found in plants (flowers, herbs, shrubs, trees, etc.). The concept does not include proteins found in vegetables for which PLANT PROTEINS, DIETARY is available. Plant Protein,Protein, Plant,Proteins, Plant
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D012697 Serine Endopeptidases Any member of the group of ENDOPEPTIDASES containing at the active site a serine residue involved in catalysis. Serine Endopeptidase,Endopeptidase, Serine,Endopeptidases, Serine
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D013917 Thrombin An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN. Thrombase,Thrombin JMI,Thrombin-JMI,Thrombinar,Thrombostat,alpha-Thrombin,beta,gamma-Thrombin,beta-Thrombin,gamma-Thrombin,JMI, Thrombin

Related Publications

Cristina I Cagliari, and Fernanda P De Caroli, and Adriana M Nakahata, and Mariana S Araújo, and Clovis R Nakaie, and Misako U Sampaio, and Claudio A M Sampaio, and Maria Luiza V Oliva
Bauhinia bauhinioides plasma kallikrein inhibitor: interaction with synthetic peptides and fluorogenic peptide substrates related to the reactive site sequence.
July 2001, Current medicinal chemistry,
Cristina I Cagliari, and Fernanda P De Caroli, and Adriana M Nakahata, and Mariana S Araújo, and Clovis R Nakaie, and Misako U Sampaio, and Claudio A M Sampaio, and Maria Luiza V Oliva
Structure of cruzipain/cruzain inhibitors isolated from Bauhinia bauhinioides seeds.
May 2001, Biological chemistry,
Cristina I Cagliari, and Fernanda P De Caroli, and Adriana M Nakahata, and Mariana S Araújo, and Clovis R Nakaie, and Misako U Sampaio, and Claudio A M Sampaio, and Maria Luiza V Oliva
Effect of plant Kunitz inhibitors from Bauhinia bauhinioides and Bauhinia rufa on pulmonary edema caused by activated neutrophils.
June 2003, Biological chemistry,
Cristina I Cagliari, and Fernanda P De Caroli, and Adriana M Nakahata, and Mariana S Araújo, and Clovis R Nakaie, and Misako U Sampaio, and Claudio A M Sampaio, and Maria Luiza V Oliva
Effect of bauhinia bauhinioides kallikrein inhibitor on endothelial proliferation and intracellular calcium concentration.
January 2014, European review for medical and pharmacological sciences,
Cristina I Cagliari, and Fernanda P De Caroli, and Adriana M Nakahata, and Mariana S Araújo, and Clovis R Nakaie, and Misako U Sampaio, and Claudio A M Sampaio, and Maria Luiza V Oliva
Synthetic inhibitors of serine proteinases. XVI. Influence of 3- and 4-amidinobenzyl derivatives on the formation and action of thrombin.
May 1978, Thrombosis research,
Cristina I Cagliari, and Fernanda P De Caroli, and Adriana M Nakahata, and Mariana S Araújo, and Clovis R Nakaie, and Misako U Sampaio, and Claudio A M Sampaio, and Maria Luiza V Oliva
Conformational and biological properties of Bauhinia bauhinioides kallikrein inhibitor fragments with bradykinin-like activities.
June 2015, Journal of peptide science : an official publication of the European Peptide Society,
Cristina I Cagliari, and Fernanda P De Caroli, and Adriana M Nakahata, and Mariana S Araújo, and Clovis R Nakaie, and Misako U Sampaio, and Claudio A M Sampaio, and Maria Luiza V Oliva
[Determination of the esterase activity of serine proteinases using synthetic substrates].
January 1991, Laboratornoe delo,
Cristina I Cagliari, and Fernanda P De Caroli, and Adriana M Nakahata, and Mariana S Araújo, and Clovis R Nakaie, and Misako U Sampaio, and Claudio A M Sampaio, and Maria Luiza V Oliva
Synthetic inhibitors of serine proteinases. 22. Inhibition of acrosin by benzamidine derivatives.
January 1980, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
Cristina I Cagliari, and Fernanda P De Caroli, and Adriana M Nakahata, and Mariana S Araújo, and Clovis R Nakaie, and Misako U Sampaio, and Claudio A M Sampaio, and Maria Luiza V Oliva
Synthetic inhibitors of serine proteinases. XXIII. Inhibition of factor Xa by diamidines.
January 1980, Thrombosis research,
Cristina I Cagliari, and Fernanda P De Caroli, and Adriana M Nakahata, and Mariana S Araújo, and Clovis R Nakaie, and Misako U Sampaio, and Claudio A M Sampaio, and Maria Luiza V Oliva
[Synthetic inhibitors of serine proteinases. 35. Inhibition action of amidino- and guanidinophenyl derivatives against hemolysis initiated by complement activation].
February 1989, Die Pharmazie,
Copied contents to your clipboard!